Table 2.
aCGH Cycles = 39 Patients = 35 |
No aCGH Cycles = 394 Patients = 311 |
IR [95 % CI] p-value |
aCGH Cycles = 39 Patients = 35 |
No aCGH Cycles = 394 Patients = 311 |
RRb/IRRc [95 % CI] p-value |
||
---|---|---|---|---|---|---|---|
Age | 37.3 (3.4) | 35.4 (4.3) | 1.9 [0.6 – 3.1] p = 0.0036 |
Implantation rate | 30/57 (52.63 %) | 253/1321 (19.15 %) | IRR = 2.66 [2.08–3.40] p < 0.0001 |
FSHa | 6.1 (2.0) | 5.9 (2.4) | 0.2 [−0.7–1.1] p = 0.6929 |
Clinical pregnancy rate | 27/39 (69.23 %) | 173/394 (43.91 %) | RR = 1.58 [1.24–1.99] p = 0.0002 |
AMHa | 2.8 (2.4) | 3.3 (3.2) | −0.5 [−1.9.0–0.9] p = 0.4619 |
Ongoing pregnancy rate | 24/39 (61.54 %) | 128/394 (32.49 %) | RR = 1.91 [1.42–2.55] p < 0.0001 |
# oocytes fertilized | 9.1 (4.9) | 8.5 (3.1) | 0.5 [−1.2 – 2.3] p = 0.5351 |
Miscarriage rate | 3/27 (11.11 %) | 45/173 (26.01 %) | RR = 0.43 [0.14–1.29] p = 0.1305 |
# embryos transferred | 1.5 (0.9) | 3.3 (1.4) | −1.8 [−2.2 – −1.3] p = <0.0001 |
Multiple pregnancy rate | 2/24 (8.33 %) | 44/128 (34.38 %) | RR = 0.17 [0.04–0.63] p = 0.0082 |
a The mixed model with a repeated statement would not converge so the mean FSH/AMH from all cycles for each patient was computed and used as the outcome measure and independence was assumed among means for estimates presented
b Relative Risk (RR) estimates used to compare probabilities
c Incidence Rate Ratio (IRR) estimates used to compare rates